Abstract
Subclinical hypothyroidism is an early and mild form of thyroid failure characterized by serum levels of thyroid hormones within their reference range but elevated serum TSH concentrations. The prevalence of subclinical hypothyroidism is 4–10% and this condition increases significantly with age. The management and treatment of subclinical hypothyroidism are controversial, and there is no consensus about the TSH concentration at which treatment should be started. The cardiovascular risk is increased in patients with overt hypothyroidism, with several potential cardiovascular risk factors similarly reported in patients with subclinical hypothyroidism. Identification of the potential cardiovascular risk factors could facilitate decision-making about the treatment of patients with subclinical hypothyroidism. Impaired left ventricular diastolic function, characterized by slowed myocardial relaxation and impaired early ventricular filling, is the most consistent cardiac abnormality identified in young and middle-aged patients with subclinical hypothyroidism. Moreover, vascular function is impaired in patients with mild and subclinical hypothyroidism, as documented by the increase in systemic vascular resistance and arterial stiffness and by the impaired endothelial function, increasing the risk of atherosclerosis and coronary artery disease. Epidemiological studies have investigated cardiovascular morbidity and mortality in patients with subclinical hypothyroidism; the results suggest that middle-aged individuals with mild thyroid hormone deficiency have a higher cardiovascular risk for coronary heart disease than the elderly with this condition. Moreover, cardiac death, particularly from ischemic heart disease, is significantly higher in cardiac patients with subclinical hypothyroidism. Replacement therapy with l-thyroxine (l-T4) may reverse the cardiovascular risk associated with subclinical hypothyroidism. For this reason, l-T4 replacement therapy should be considered in subclinically hypothyroid patients who have associated high cardiovascular risk factors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Biondi B, Cooper DS (2008) The clinical significance of subclinical thyroid dysfunction. Endocr Rev 229:76–131
Cooper DS (2001) Clinical practice. Subclinical hypothyroidism. N Engl J Med 345:260–265
Vanderpump MP, Tunbridge WM, French JM et al (1995) The incidence of thyroid disease in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 43:55–68
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC (2000) The Colorado thyroid disease prevalence study. Arch Intern Med 160:526–534
Hollowell JG, Staehling NW, Flanders WD et al (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499
Huber G, Staub JJ, Meier C et al (2002) Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 87:3221–3226
Gharib H, Tuttle RM, Baskin HJ et al (2005) Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 90:581–585
Surks MI, Ortiz E, Daniels GH et al (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228–238
Biondi B, Palmieri EA, Lombardi G, Fazio S (2002) Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137:904–914
Biondi B, Palmieri EA, Lombardi G, Fazio S (2002) Subclinical hypothyroidism and cardiac function. Thyroid 12:505–510
Biondi B (2007) Cardiovascular effects of mild hypothyroidism. Thyroid 17:625–630
Bough EW, Crowley WF, Ridgway EC et al (1978) Myocardial function in hypothyroidism: relation to disease severity and response to treatment. Arch Intern Med 138:1476–1480
Cooper DS, Halpern R, Wood LC, et al (1984) Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med 101:18–24
Staub JJ, Althaus BU, Engler H et al (1992) Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 92:631–642
Vitale G, Galderisi M, Lupoli, GA et al (2002) Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a new ultrasound tool: pulsed tissue Doppler. J Clin Endocrinol Metab 87:4350–4355
Monzani F, Di Bello V, Caraccio N et al (2001) Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab 86:1110–1115
Yazici M, Gorgulu S, Sertbas Y et al (2004) Effects of thyroxin therapy on cardiac function in patients with subclinical hypothyroidism: index of myocardial performance in the evaluation of left ventricular function. Int J Cardiol 95:135–143
Biondi B, Fazio S, Palmieri EA et al (1999) Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 84:2064–2067
Aghini-Lombardi F, Di Bello V, Talini E et al (2006) Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism. Eur J Endocrinol 155:3–9
Kahaly GJ (2000) Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10:665–679
Brenta G, Mutti LA, Schnitman M et al (2003) Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy. Am J Cardiol 91:1327–1330
Bell GM, Todd WT, Forfar JC et al (1985) End-organ responses to thyroxine therapy in subclinical hypothyroidism. Clin Endocrinol 22:83–89
Forfar JC, Wathen CG, Todd WT et al (1985) Left ventricular performance in subclinical hypothyroidism. Q J Med 57:857–865
Di Bello V, Monzani F, Giorgi D et al (2000) J Am Soc Echocardiogr 13:832–840
Ripoli A, Pingitore A, Favilli B et al (2005) Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. J Am Coll Cardiol 45:439–445
Biondi B, Klein I (2004) Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 24:1–13
Galderisi M, Vitale G, D’Errico A et al (2004) Usefulness of pulsed tissue Doppler for the assessment of left ventricular myocardial function in overt hypothyroidism. Ital Heart J 5:257–264
Iqbal A, Schirmer H, Lunde P et al (2007) Thyroid stimulating hormone and left ventricular function. J Clin Endocrinol Metab 92:3504–3510
Cappola AR (2007) Subclinical thyroid dysfunction and the heart. J Clin Endocrinol Metab 92:3404–3405
Rodondi N, Newman AB, Vittinghoff E et al (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460–2466
Cappola AR, Ladenson PW (2003) Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 88:2438–2444
Faber J, Petersen L, Wiinberg N et al (2002) Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. Thyroid 12:319–324
Owen PJD, Rajiv C, Vinereanu D et al (2006) Subclinical hypothyroidism, arterial stiffness and myocardial reserve. J Clin Endocrinol Metab 9:2126–2132
Nagasaki T, Inaba M, Kumeda Y et al (2006) Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab 91:154–158
Nagasaki T, Inaba M, Kumeda Y et al (2007) Central pulse wave velocity is responsible for increased brachial-ankle pulse wave velocity in subclinical hypothyroidism. Clin Endocrinol (Oxf) 66:304–308
Taddei S, Caraccio N, Virdis A et al (2003) Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88:3731–3737
Razvi S, Ingoe L, Keeka G et al (2007) The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function and quality of life in subclinical hypothyroidism: randomised, crossover trial. J Clin Endocrinol Metab 92:1715–1723
Monzani F, Caraccio N, Kozakowa M et al (2004) Effect of levothyroxine replacement on lipid profile and intimamedia thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab 89:2099–2106
Vanderpump MP, Tunbridge WM, French JM et al (1996) The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 6:155–1560
Hak AE, Pols HA, Visser TJ et al (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132:270–278
Parle JV, Maisonneuve P, Sheppard MC et al (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861–865
Cappola AR, Fried LP, Arnold AM et al (2006) Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295:1033–1041
Imaizumi M, Akahoshi M, Ichimaru S et al (2004) Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 89:3365–3370
Walsh JP, Bremmer AP, Bulsara MK et al (2005) Thyroid dysfunction and serum lipids: a community-based study. Clin Endocrinol (Oxf) 63:670–675
Biondi B (2008) Should we treat all subjects with subclinical thyroid disease the same way? Eur J Endocrinol 159:343–345
Völzke H, Schwahn C, Wallaschofski H, Dörr M (2007) The association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? J Clin Endocrinol Metab 92:2421–2429
Gussekloo J, van Exel E, de Craen AJ et al (2004) Thyroid status, disability and cognitive function, and survival in old age. JAMA 292:2591–2599
Ochs N, Auer R, Bauer DC et al (2008) Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 148:832–845
Iervasi G, Molinaro S, Landi P et al (2007) Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med 167:1526–1532
Chen HS, Wu TE, Jap TS et al (2007) Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular disease in type 2 diabetic patients. Diabet Med 24: 1336–1344
Razvi S, Shakoor A, Vanderpump M et al (2008) The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a meta-analysis. J Clin Endocrinol Metab 93:2998–3007
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Italia
About this chapter
Cite this chapter
Biondi, B. (2009). Cardiac Morphology and Function in Mild Hypothyroidism. In: Iervasi, G., Pingitore, A. (eds) Thyroid and Heart Failure. Springer, Milano. https://doi.org/10.1007/978-88-470-1143-4_3
Download citation
DOI: https://doi.org/10.1007/978-88-470-1143-4_3
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1142-7
Online ISBN: 978-88-470-1143-4
eBook Packages: MedicineMedicine (R0)